Haemonetics (HAE) Short Interest Ratio & Short Volume $119.94 +0.75 (+0.63%) Closing price 10/27/2026 03:59 PM EasternExtended Trading$120.20 +0.26 (+0.22%) As of 10/27/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Haemonetics Short Interest OverviewAs of October 15, 2026, Haemonetics (HAE) had a short interest of 3.43 million shares sold short, representing 7.69% of the public float. This marks a 12.85% increase in short interest since the prior report. The short interest ratio (days to cover) is 3.9, meaning it would take 3.9 days of the average trading volume of 0 shares to cover all short positions.Current Short Interest3,428,091 sharesPrevious Short Interest3,037,763 sharesChange Vs. Previous Month12.85%Dollar Volume Sold Short$417.01 millionShort Interest Ratio3.9 Days to CoverLast Record DateOctober 15, 2026Outstanding Shares45,500,000 sharesShort Percent of Float7.69%Today's Trading Volume900,879 sharesAverage Trading Volume0 sharesToday's Volume Vs. Average∞ Short Selling Haemonetics? Sign up to receive the latest short interest report for Haemonetics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHAE Short Interest Over TimeHAE Days to Cover Over TimeHAE Percentage of Float Shorted Over Time Haemonetics Tesla Short Interest History & Recent Changes ExportReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20263,428,091 shares $417.01 million +12.9%7.7%3.89 $121.64 9/30/20263,037,763 shares $320.73 million -11.3%6.8%5.34 $105.58 9/15/20263,424,696 shares $363.90 million +19.6%7.7%5.69 $106.26 8/31/20262,863,501 shares $294.14 million +3.7%6.4%3.4 $102.72 8/14/20262,761,115 shares $250.88 million -5.5%6.2%3.11 $90.86 7/31/20262,921,809 shares $249.86 million +8.2%6.6%4.57 $85.51 7/15/20262,701,605 shares $207.56 million -7.3%6.1%4.22 $76.83 6/30/20262,914,882 shares $219.18 million -3.3%6.5%3.13 $75.20 6/15/20263,013,604 shares $231.35 million +1.9%6.8%2.7 $76.77 5/29/20262,956,590 shares $201.10 million +14.5%6.6%3.1 $68.02 Get the Latest News and Ratings for HAE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Haemonetics and its competitors with MarketBeat's FREE daily newsletter. 5/15/20262,583,187 shares $145.54 million +30.5%5.8%2.43 $56.34 4/30/20261,980,212 shares $118.91 million -0.8%4.3%2.91 $60.05 4/15/20261,995,363 shares $123.45 million -3.8%4.5%3.68 $61.87 3/31/20262,073,575 shares $116.83 million +8.9%4.7%2.55 $56.34 3/13/20261,904,947 shares $114.15 million -29.7%4.2%2.42 $59.93 2/27/20262,709,643 shares $171.48 million +6.8%5.9%3.46 $63.28 2/13/20262,537,146 shares $146.59 million +5.2%5.7%2 $57.78 1/30/20262,411,300 shares $160.46 million -21.7%5.3%2.6 $66.54 1/15/20263,077,776 shares $227.52 million -11.9%6.7%4.26 $73.92 12/31/20253,491,564 shares $279.81 million +3.0%7.6%6.13 $80.14 12/15/20253,389,295 shares $272.64 million -6.4%7.4%3.84 $80.44 11/28/20253,621,526 shares $294.61 million +21.0%7.9%4.45 $81.35 11/14/20252,991,990 shares $219.84 million -4.2%6.3%1.88 $73.48 10/31/20253,123,353 shares $156.21 million -6.4%6.6%5.56 $50.01 10/15/20253,340,000 shares $162.42 million +6.7%7.0%3.3 $48.63 9/30/20253,130,000 shares $152.52 million -7.7%6.6%3.2 $48.73 9/15/20253,390,000 shares $174.21 million -7.6%7.1%3.5 $51.39 8/31/20253,670,000 shares $200.49 million -16.0%7.7%4.5 $54.63 8/15/20254,370,000 shares $235.32 million +41.9%9.2%5.6 $53.85 7/31/20253,080,000 shares $228.04 million -12.0%6.5%4.5 $74.04 7/15/20253,500,000 shares $261.03 million -4.4%7.4%6.3 $74.58 6/30/20253,660,000 shares $273.66 million -9.9%7.7%6.1 $74.77 6/15/20254,060,000 shares $284.28 million -1.5%8.6%6.8 $70.02 5/31/20254,120,000 shares $278.84 million +1.0%8.7%6.3 $67.68 5/15/20254,080,000 shares $282.99 million -6.2%8.6%5.7 $69.36 4/30/20254,350,000 shares $274.27 million -1.8%8.8%4.8 $63.05 4/15/20254,430,000 shares $258.14 million -2.2%8.9%4.5 $58.27 3/31/20254,530,000 shares $288.33 million -24.9%9.1%4.7 $63.65 3/15/20256,030,000 shares $396.54 million -6.8%12.1%6.6 $65.76 2/28/20256,470,000 shares $423.79 million -5.3%13.0%7.5 $65.50My next big call (under $1) (Ad)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community before the big move happened. Now, I'm making my next big call. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage. With Bitcoin well off its highs and fear still hanging over the market, this is the exact environment where my biggest winners have been found.Click to see my #1 pick. 2/15/20256,830,000 shares $426.65 million +30.3%13.8%8.6 $62.47 1/31/20255,240,000 shares $361.03 million +5.7%10.6%6.7 $68.90 1/15/20254,960,000 shares $371.75 million -5.2%10.0%8.3 $74.95 12/31/20245,230,000 shares $408.36 million +6.5%10.5%9.4 $78.08 12/15/20244,910,000 shares $398.64 million +7.4%9.9%8.3 $81.19 11/30/20244,570,000 shares $399.74 million -0.2%9.2%7.5 $87.47 11/15/20244,580,000 shares $408.72 million -11.2%9.2%7.4 $89.24 10/31/20245,160,000 shares $367.13 million -1.9%10.4%8.4 $71.15 10/15/20245,260,000 shares $395.55 million -3.0%10.4%9 $75.20 9/30/20245,420,000 shares $435.44 million +0.4%10.7%9.4 $80.34 9/15/20245,400,000 shares $410.89 million -11.3%10.7%9 $76.09 8/31/20246,090,000 shares $460.28 million +20.6%12.0%10.5 $75.58 8/15/20245,050,000 shares $373.45 million +5.2%10.0%7.7 $73.95 7/31/20244,800,000 shares $432.29 million +2.8%9.5%7.7 $90.06 7/15/20244,670,000 shares $421.23 million +10.7%9.3%7.9 $90.20 6/30/20244,220,000 shares $349.12 million +8.2%8.4%7.2 $82.73 6/15/20243,900,000 shares $330.17 million +19.6%7.7%7 $84.66 5/31/20243,260,000 shares $274.04 million +30.4%6.5%6.1 $84.06 5/15/20242,500,000 shares $241.15 million -4.6%5.0%4.9 $96.46 4/30/20242,620,000 shares $241.17 million +17.0%5.2%5.3 $92.05 4/15/20242,240,000 shares $190.20 million +9.8%4.5%4.7 $84.91 3/31/20242,040,000 shares $174.11 million -6.4%4.1%4.5 $85.35 3/15/20242,180,000 shares $163.02 million +11.2%4.3%4.9 $74.78 2/29/20241,960,000 shares $143.02 million +6.5%3.9%4.7 $72.97 2/15/20241,840,000 shares $132.26 million +10.2%3.7%4.8 $71.88 1/31/20241,670,000 shares $127.65 million -1.8%3.3%5 $76.44 1/15/20241,700,000 shares $141.10 million -6.6%3.4%5.7 $83.00 12/31/20231,820,000 shares $155.63 million +9.0%3.6%6.3 $85.51 12/15/20231,670,000 shares $149.21 million -1.2%3.3%5.8 $89.35 11/30/20231,690,000 shares $136.69 million -6.1%3.4%6.1 $80.88 11/15/20231,800,000 shares $160.63 million +7.1%3.6%6.5 $89.24 10/31/20231,680,000 shares $143.19 million +18.3%3.4%5.9 $85.23 10/15/20231,420,000 shares $126.89 million -17.0%2.8%5 $89.36 9/30/20231,710,000 shares $153.18 million +6.9%3.4%5.9 $89.58 9/15/20231,600,000 shares $144.16 million +1.3%3.2%5.6 $90.10 8/31/20231,580,000 shares $141.77 million +21.5%3.2%5.4 $89.73 8/15/20231,300,000 shares $120.68 million -6.5%2.6%4.4 $92.83 7/31/20231,390,000 shares $128.07 million +6.9%2.8%4.6 $92.14 7/15/20231,300,000 shares $109.20 million -8.5%2.6%4.4 $84.00 6/30/20231,420,000 shares $120.90 million -2.7%2.8%5.1 $85.14 6/15/20231,460,000 shares $121.82 million +9.8%2.9%4.9 $83.44 5/31/20231,330,000 shares $112.62 million +23.2%2.7%4.5 $84.68 5/15/20231,080,000 shares $96.29 million +3.9%2.2%3.5 $89.16 4/30/20231,040,000 shares $87.06 million -21.2%2.1%3.2 $83.71 4/15/20231,320,000 shares $111.91 million +24.5%2.6%3.6 $84.78 3/31/20231,060,000 shares $87.72 million -13.1%2.1%2.6 $82.75 3/15/20231,220,000 shares $93.50 million -3.2%2.4%3 $76.64 2/28/20231,260,000 shares $97.99 million +2.4%2.5%3 $77.77 2/15/20231,230,000 shares $102.61 million -3.9%2.5%3 $83.42 1/31/20231,280,000 shares $108.29 million +2.4%2.6%2.8 $84.60My next big call (under $1) (Ad)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community before the big move happened. Now, I'm making my next big call. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage. With Bitcoin well off its highs and fear still hanging over the market, this is the exact environment where my biggest winners have been found.Click to see my #1 pick. 1/15/20231,250,000 shares $107.14 million +7.8%2.5%2.9 $85.71 12/30/20221,160,000 shares $91.23 million +4.5%2.3%2.8 $78.65 12/15/20221,110,000 shares $85.80 million -2.6%2.2%2.6 $77.30 11/30/20221,140,000 shares $97.25 million -7.3%2.3%2.8 $85.31 11/15/20221,230,000 shares $95.99 million -26.4%2.5%2.9 $78.04 10/31/20221,670,000 shares $141.87 million +1.8%3.3%3.9 $84.95 10/15/20221,640,000 shares $125.53 million +10.8%3.2%4 $76.54 9/30/20221,480,000 shares $109.56 million -14.0%2.9%3.8 $74.03 9/15/20221,720,000 shares $133.54 million -7.5%3.4%4 $77.64 8/31/20221,860,000 shares $139.56 million +6.3%3.7%4.4 $75.03 8/15/20221,750,000 shares $132.79 million -3.9%3.5%4.2 $75.88 7/31/20221,820,000 shares $126.47 million -2.7%3.6%4 $69.49 7/15/20221,870,000 shares $119.85 million -2.1%3.7%4.1 $64.09 6/30/20221,910,000 shares $124.49 million +5.0%3.8%3.9 $65.18 6/15/20221,820,000 shares $112.46 million +7.1%3.6%3.8 $61.79 5/31/20221,700,000 shares $107.54 million -7.6%3.4%3.5 $63.26 5/15/20221,840,000 shares $103.48 million +8.2%3.6%3.6 $56.24 4/30/20221,700,000 shares $86.14 million +3.0%3.4%3.1 $50.67 4/15/20221,650,000 shares $93.75 million +0.6%3.3%2.9 $56.82 3/31/20221,640,000 shares $103.68 million -16.3%3.2%2.8 $63.22 3/15/20221,960,000 shares $105.60 million +8.9%3.9%3.3 $53.88 2/28/20221,800,000 shares $103.88 million +18.4%3.6%3 $57.71 2/15/20221,520,000 shares $88.75 million +23.6%3.0%2.6 $58.39 1/31/20221,230,000 shares $59.47 million +2.5%2.4%2.1 $48.35 1/15/20221,200,000 shares $63.23 million -1.6%2.4%2.4 $52.69 12/31/20211,220,000 shares $64.71 million -6.2%2.4%2.5 $53.04 12/15/20211,300,000 shares $65.82 million -3.0%2.6%2.8 $50.63 11/30/20211,340,000 shares $68.68 million -3.6%2.7%2.9 $51.25 11/15/20211,390,000 shares $80.48 million -15.8%2.8%3 $57.90 10/29/20211,650,000 shares $113.37 million -14.1%3.3%3.4 $68.71 HAE Short Interest - Frequently Asked Questions What is Haemonetics' current short interest? Short interest is the volume of Haemonetics shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 3,428,091 shares of HAE short. 7.69% of Haemonetics' shares are currently sold short. Learn More on Haemonetics' current short interest. What is a good short interest ratio for Haemonetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HAE shares currently have a short interest ratio of 3.9. Learn More on Haemonetics's short interest ratio. What is a good short interest percentage for Haemonetics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.69% of Haemonetics' floating shares are currently sold short. Is Haemonetics' short interest increasing or decreasing? Haemonetics saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 3,428,091 shares, an increase of 12.8% from the previous total of 3,037,763 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Haemonetics' short interest compare to its competitors? 7.69% of Haemonetics' shares are currently sold short. Here is how the short interest of companies in the sector of "healthcare" compare to Haemonetics: DexCom, Inc. (4.17%), HealthEquity, Inc. (7.30%), Lantheus Holdings, Inc. (5.66%), Insulet Corporation (8.15%), Quanterix Corporation (10.04%), SiBone (11.05%), Penumbra, Inc. (5.92%), Zimmer Biomet Holdings, Inc. (4.23%), Baxter International Inc. (4.60%), Smith & Nephew SNATS, Inc. (0.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.77 billion), Invesco QQQ ($59.70 billion), iShares Russell 2000 ETF ($23.54 billion), Medtronic PLC ($13.33 billion), SPDR S&P Biotech ETF ($10.47 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($10.36 billion), Nebius Group N.V. ($8.98 billion), iShares 20+ Year Treasury Bond ETF ($8.92 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($8.10 billion), and iShares Semiconductor ETF ($7.74 billion). View all of the most shorted stocks. What does it mean to sell short Haemonetics stock? Short selling HAE is an investing strategy that aims to generate trading profit from Haemonetics as its price is falling. HAE shares are trading up $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Haemonetics? A short squeeze for Haemonetics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HAE, which in turn drives the price of the stock up even further. How often is Haemonetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HAE, twice per month. The most recent reporting period available is October, 15 2026. What do HAE's short interest metrics mean? Understanding short interest metrics can help you assess how traders are positioning around a stock like HAE:Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity. More Short Interest Resources from MarketBeat Related Companies DexCom Short Interest HealthEquity Short Interest Lantheus Short Interest Insulet Short Interest Quanterix Short Interest SiBone Short Interest Penumbra Short Interest Zimmer Biomet Short Interest Baxter International Short Interest Smith & Nephew SNATS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates Short interest data for NYSE:HAE is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/26/2026. FINRA publishes updated short interest twice a month. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
